HIGHLIGHTS
- who: Shu-guang Yang from the of China, Henan University of Chinese Medicine, Zhengzhou, Henan have published the research: Efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial, in the Journal: (JOURNAL) of December/11,/2019
- what: This study is to evaluate the efficacy and safety of JHG for IPF. Dropu2011out criteria Drop-out criteria have been set up as follows: not willing to continue the trial with any reason and may induce the incompleteness of study data, should not . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.